Microbiome Therapeutics Try a Lighter Touch

U.S. Food and Drug Administration. Important safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse reactions due to transmission of multi-drug resistant organisms. Published June 13, 2019. Updated December 4, 2020. Accessed March 1, 2022. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious-adverse.

Guo Z , Zhang J , Wang Z , et al. Intestinal microbiota distinguish gout patients from healthy humans. Sci. Rep. , 2016; 6: 20602. DOI: 10.1038/srep20602.

Chu Y , Sun S , Huang Y , et al. Metagenomic analysis revealed the potential role of gut microbiome in gout. NPJ Biofilms Microbiomes , 2021; 7: 66. DOI: 10.1038/s41522-021-00235-2.

Larkin J , Chiarion-Sileni V , Gonzalez R , et al. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. N. Engl. J. Med. , 2019; 381: 1535–1546. DOI: 10.1056/NEJMoa1910836.

Matson V , Fessler J , Bao R , et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science , 2018; 359(6371): 104–108. DOI: 10.1126/science.aao3290.

Frankel AE , Coughlin LA , Kim J , et al. Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia , 2017; 19(10): 848–855. DOI: 10.1016/j.neo.2017.08.004.

Robinson MJ , Vervier K , Harris S , et al. Precision microbiome profiling identifies a novel biomarker predictive of Immune Checkpoint Inhibitor response in multiple cohorts and a potent therapeutic consortium of bacteria. Abstract presented at: American Association for Cancer Research Annual Meeting; Apr 10–15 and May 17–21, 2021; Philadelphia, PA. Cancer Res . 2021; 81(13_Suppl.): Abstract 1783. DOI: 10.1158/1538-7445.AM2021-1783.

Baruch EN , Youngster I , Ben-Betzalel G , et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science , 2021; 371(6529): 602–609. DOI: 10.1126/science.abb5920.

Davar D , Dzutsev AK , McCulloch JA , et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science , 2021; 371(6529): 595–602. DOI: 10.1126/science.abf3363.

National Organization for Rare Disorders. STEC Hemolytic Uremic Syndrome. Accessed March 1, 2022. https://rarediseases.org/rare-diseases/stec-hemolytic-uremic-syndrome/.

Poore GD , Kopylova E , Zhu Q , et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature , 2020; 579(7800): 567–574. DOI: 10.1038/s41586-020-2095-1.